These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 22955021)

  • 1. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic approaches in myositis.
    Aggarwal R; Oddis CV
    Curr Rheumatol Rep; 2011 Jun; 13(3):182-91. PubMed ID: 21365210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on therapy for refractory dermatomyositis and polymyositis.
    Villalba L; Adams EM
    Curr Opin Rheumatol; 1996 Nov; 8(6):544-51. PubMed ID: 9018458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the pharmacological treatment of adult myositis.
    Oddis CV
    J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of polymyositis and dermatomyositis.
    Marie I; Mouthon L
    Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of methotrexate in inflammatory myopathies.
    Fendler C; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New therapeutic approaches for polymyositis and dermatomyositis].
    Dankó K; Vincze M
    Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of idiopathic inflammatory myopathies.
    Amato AA; Griggs RC
    Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report.
    Chang HK; Lee DH
    J Korean Med Sci; 2003 Feb; 18(1):131-4. PubMed ID: 12589104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory polymyositis and dermatomyositis.
    Ytterberg SR
    Curr Rheumatol Rep; 2006 Jun; 8(3):167-73. PubMed ID: 16901073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Gordon PA; Winer JB; Hoogendijk JE; Choy EH
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003643. PubMed ID: 22895935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T; Kanda H; Kubo K
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory myopathies: management of steroid resistance.
    Dalakas MC
    Curr Opin Neurol; 2011 Oct; 24(5):457-62. PubMed ID: 21799409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients.
    Efthimiou P; Schwartzman S; Kagen LJ
    Ann Rheum Dis; 2006 Sep; 65(9):1233-6. PubMed ID: 16476710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.